Extramural Research Programs in the Neurosciences and Neurological Disorders in Colorado
Extramural Research Programs in the Neurosciences and Neurological Disorders (93.853) awarded $119 million to recipients in Colorado in 149 grants from fiscal 2021 to 2025, 1.3% of the program's national total. The Regents of the University of Colorado received the most, $86.0 million.
- Awarded in Colorado$119 million
- Awards149
- Share of the program1.3%
- Rank among states20th of 52
- National total$9.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 59 | $20.2 million |
| FY 2022 | 65 | $21.0 million |
| FY 2023 | 78 | $24.5 million |
| FY 2024 | 78 | $28.3 million |
| FY 2025 | 66 | $24.7 million |
Recipients in Colorado
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Regents of the University of Colorado | Colleges and universities | 106 | $86.0 million |
| Colorado State University | Colleges and universities | 16 | $17.3 million |
| The Regents of the University of Colorado | Colleges and universities | 8 | $5.6 million |
| Neurexis Therapeutics, Inc. | Small businesses | 3 | $4.2 million |
| Vulintus, Inc | Small businesses | 1 | $1.9 million |
| Trustees of the Colorado School of Mines | Colleges and universities | 1 | $989,585 |
| University of Denver | Colleges and universities | 1 | $964,023 |
| Armis Biopharma, Inc. | Small businesses | 1 | $654,950 |
| The Regents of the University of Colorado | Colleges and universities | 1 | $436,637 |
| Xtract Medical Inc | Small businesses | 1 | $382,043 |
Open opportunities under this program
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
- HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
See all 104 on the program page
Questions people ask
How much Extramural Research Programs in the Neurosciences and Neurological Disorders money goes to Colorado?
$119 million from fiscal 2021 to 2025, across 149 awards. Colorado ranks 20th of 52 states and territories for this program.
Who receives Extramural Research Programs in the Neurosciences and Neurological Disorders money in Colorado?
The largest recipient is The Regents of the University of Colorado, with $86.0 million in 106 awards. Next are Colorado State University and The Regents of the University of Colorado.
Can organizations in Colorado apply now?
Yes, 104 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Extramural Research Programs in the Neurosciences and Neurological Disorders in other states
Other large programs in Colorado
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Airport Improvement Program, Infrastructure Investment and Jobs Act Programs, and COVID-19 Airports Programs
- 1332 State Innovation Waivers
- Special Education Grants to States
- Federal Transit Formula Grants